Madrigal Pharmaceuticals (MDGL)
(Delayed Data from NSDQ)
$229.58 USD
-5.27 (-2.24%)
Updated May 24, 2024 04:00 PM ET
After-Market: $229.75 +0.17 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 36% (90 out of 250)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.47 | 1.52 | 9.99 |
Current Quarter Estimate | -7.55 | -2.04 | 57.00 |
Year Ago Quarter Estimate | -4.69 | -0.59 | 52.54 |
Next Quarter Estimate | -6.96 | -2.00 | 61.00 |
Next Year Estimate | -17.59 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -38.17 | 13.40 | 15.67 |
Next Year | 36.31 | 14.10 | 9.31 |
Last 5 Years | -303.80 | 6.90 | 8.10 |
Next 5 Years | NA | 23.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 5.74 | 1.89 |
Price/Cash Flow (MRFY) | NA | 8.49 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -67.62% |
Return on Equity (TTM) | -128.60% | -59.74% |
Debt to Equity (MRQ) | 0.14 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.